The promise of mRNA technology seemed boundless after the success of the coronavirus vaccines, but Robert F. Kennedy Jr. has ...

Among the eight people who Robert F. Kennedy Jr. announced would make up his new group of outside vaccine advisers to the US Centers for Disease Control and Prevention are an emergency physician who ...

Sanofi (NASDAQ: SNY) is one of the 11 Best Drug Stocks to Buy According to Hedge Funds. Berenberg Bank analyst Luisa Hector ...

Novavax, Inc. faces profitability challenges despite a promising tech platform, with uncertain revenue streams. Click for my ...

And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured ...

Robert F. Kennedy Jr., the health secretary, dismissed 17 scientific advisers to the C.D.C. Critics fear newly appointed ...

If the Senate passes the budget reconciliation bill, one in three adults who work or attend school while enrolled in Medicaid ...

AMA’s new president argues against federal budget cuts at the group’s annual policy meeting, where physicians oppose RFK Jr’s ...

BioNTech is acquiring CureVac in a deal that brings messenger RNA manufacturing capability and cancer immunotherapy ...

Three years after litigation started over technology used in an mRNA vaccine for COVID-19, Biontech SE is acquiring its ...

German biotech firm BioNTech has agreed to acquire domestic peer CureVac for about $1.25 billion worth of BioNTech shares, it ...

BioNTech has agreed to acquire mRNA specialist CureVac for approximately $1.25bn, as the big pharma company amps up its strategy to offer cancer treatments using the modality. According to the deal, ...